Long-Term Metformin Use Linked to Fewer ER+ Breast Cancers Long-Term Metformin Use Linked to Fewer ER+ Breast Cancers

Observational data from over 40,000 women with type 2 diabetes documents fewer estrogen receptor-positive breast cancers in those treated with metformin long-term; editorialists question conclusions, however.Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news